Prospective Evaluation of Near and Intermediate Visual Outcomes With Monofocal Intraocular Lenses: The Mast Study
1 other identifier
observational
200
1 country
1
Brief Summary
The purpose of this study is to evaluate the near and intermediate visual outcomes of patients who have undergone routine cataract surgery (removal of cloudy crystalline lens) with phacoemulsification (the break-up and removal of cloudy lens) and monofocal IOL ( a plastic lens implanted to replace eye's natural lens) placement in the capsular bag in at least one eye.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 27, 2010
CompletedFirst Posted
Study publicly available on registry
August 30, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedJune 14, 2012
June 1, 2012
2.2 years
August 27, 2010
June 13, 2012
Conditions
Keywords
Study Arms (2)
Near visual outcomes with Monofocal IOL
Evaluation of intermediate visual outcomes of patients undergoing routine cataract surgery with phacoemulsification and monofocal IOl placement in the capsular bag in at least one eye.
Intermediate Visual outcomes
Evaluation of intermediate visual outcomes of patients undergoing routine cataract surgery with phacoemulsification and monofocal IOl placement in the capsular bag in at least one eye.
Interventions
Monofocal Intraocular Lenses
Eligibility Criteria
Prospective evaluation of 200 patients male or female at least 18 years of age who have previously undergone phacoemulsification (the break-up and removal of a cataract) between one and 36 months earlier
You may qualify if:
- Male or female patients at least 18 years of age
- Patients who underwent routine cataract surgery with phacoemulsification and monofocal iol placement in the capsular bag in at least one eye within the last 36 months
- At least 1 month postop before follow-up evaluation
- All Patients must have a DCVA of 20/25 or better
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Innovative Medicallead
- Staar Surgical Companycollaborator
Study Sites (1)
Advanced Vision Institute
Williamsburg, Virginia, 23188, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Glenn Campbell, MD
Advanced Vision Institute
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 27, 2010
First Posted
August 30, 2010
Study Start
August 1, 2010
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
June 14, 2012
Record last verified: 2012-06